Cytochrome p450 genes (pharmacogenetics)

panel Farmacogenetics (CYP450 general and cardiology) ¹

This test is available for the following conditions:

• Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)
• Conditions > Pharmacogenetics > Panels

Turnaround time
Targeted analysis: max. 10 business days

Method

• Targeted analysis of multiple genes and variants

Remarks
Panel contains the following genes: CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, SLCO1B1, VKORC1. (Variants per gene)

Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood

---

panel Farmacogenetics (CYP450 psychiatry) ¹

This test is available for the following conditions:

• Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)
• Conditions > Pharmacogenetics > Panels

Turnaround time
Targeted analysis: max. 10 business days

Method

• Targeted analysis of multiple genes and variants

Remarks
Panel contains the following genes: CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5. (Variants per gene)

Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood

---

CYP2C19 - cytochrome P450 2C19 (pharmacogenetics) ¹

This test is available for the following conditions:

• Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)

This product is also part of the following panels:

• Mendelian inherited disorders panel

Turnaround time
Targeted analysis: max. 10 business days

Method

• Targeted analysis of one or more variants

Remarks
Analysis of CYP2C19*1 t/m *10 en *17. Risk factor for delayed metabolism of anticoagulants, anticonvulsants, antidepressants, etc.

OMIM: 124020
Performing laboratory: Maastricht UMC+
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---